ロード中...
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...
保存先:
| 出版年: | Tuberc Respir Dis (Seoul) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6030660/ https://ncbi.nlm.nih.gov/pubmed/29926556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2018.0040 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|